放疗参数与围手术期并发症对乳房再造结局的影响
结果显示放疗前并发症不延迟PMRT,严重皮炎不延迟置换,IMRT和质子治疗较3DCRT减少严重皮炎,bolus增加皮炎风险。
要点
- 放疗前手术部位并发症不延迟PMRT启动(P=0.61)。
- 严重皮炎不延迟扩张器-假体置换(P=0.63)。
- IMRT和质子治疗较3DCRT减少严重皮炎,bolus增加皮炎风险。
核心结论
- 在PMRT与再造同机构完成的整合诊疗环境中,放疗前并发症与PMRT延迟无关,放疗后并发症或急性毒性不改变假体置换进程。
主要发现
- 多数(87.5%)接受双阶段再造。
- 约四分之一乳房在PMRT前出现不良手术部位结局,PMRT后比例相似。
- 放疗前手术部位结局未延迟PMRT(P=0.61),严重皮炎未延迟扩张器-假体置换(P=0.63)。
- 严重皮炎在IMRT(P<0.01)和质子治疗(P<0.02)中较3DCRT更少,bolus使用增加皮炎风险(P<0.01)。
- 胸肌前与胸肌下再造后严重包膜挛缩差异未达统计学显著性(P=0.30)。
临床怎么用
- 放疗前手术部位并发症不应作为延迟PMRT的理由。
- 严重皮炎不构成延迟扩张器-假体置换的依据。
- 优先选择IMRT或质子治疗以减少严重皮炎,慎用bolus。
- 需多学科协作规划与沟通以优化治疗与结局。
局限性
- 单中心回顾性设计。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Postmastectomy radiation therapy (PMRT) is a key component of breast cancer care, reducing locoregional recurrence in appropriately selected patients. Concurrently, use of mastectomy with implant-based breast reconstruction has expanded, heightening attention to how patient, surgical, and radiation factors interact. There is a knowledge gap in how reconstructive strategies and PMRT parameters jointly influence complications, toxicities, and treatment timing across the expander-implant continuum. OBJECTIVE: The aim of this study was to determine how reconstructive and radiation therapy (RT) parameters relate to surgical-site complications, delays in PMRT initiation, acute radiation toxicities, delays in expander-to-implant exchange, and capsular contracture. METHODS: This study examined a single-center retrospective cohort of women undergoing mastectomy with immediate tissue expander or direct-to-implant reconstruction and PMRT (2017-2022). Complications classified as postmastectomy pre-RT, intra-RT, and post-RT. Associations between clinical and radiation factors and complications, toxicities, and delays were estimated using generalized estimating equation logistic models. RESULTS: One hundred forty-six patients underwent 260 mastectomies, and 152 reconstructions received PMRT. The majority underwent dual-stage reconstruction (87.5%). Adverse surgical site outcomes occurred in approximately one-quarter of breasts before PMRT and in a similar proportion after PMRT. Neither pre-RT surgical site outcomes delayed PMRT ( P = 0.61) nor did severe dermatitis delay expander-to-implant exchange ( P = 0.63). Severe dermatitis was less frequent with intensity-modulated RT ( P < 0.01) and proton therapy ( P < 0.02) than with three-dimensional conformal RT, whereas bolus use increased the risk of dermatitis ( P < 0.01). Severe capsular contracture occurred less frequently after prepectoral versus submuscular reconstruction, but the difference did not reach statistical significance ( P = 0.30). CONCLUSIONS: In an integrated care setting where PMRT and reconstruction are performed in the same institution, pre-RT complications do not correlate with delaying PMRT, nor do post-RT complications or acute toxicities alter the implant exchange course. Complications were substantial during the pre-RT period, suggesting further opportunities for improvement. These findings emphasize the importance of multidisciplinary planning/communication to optimize patient treatment and outcomes.
引用
- Khan S, Olsen TC, Voytik M, et al. The Relationship of Radiation Therapy Parameters and Perioperative Morbidity and Toxicities on Breast Reconstruction Outcomes. Ann Plast Surg. 2026. PMID: 41628394. doi:10.1097/SAP.0000000000004647
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。